The 2022 CGA-IGC Award fostering clinical innovations in Latin America
This year’s CGA-IGC Award is granted to Giovana Tardin Torrezan, PhD, Investigator at the Clinical and Functional Genomics Group, Hospital A. C. Camargo, São Paulo, Brazil.
Torrezan's research is focused on KRAS-G12C: The neglected biomarker for identifying MUTYH-associated polyposis patients.
Giovana Tardin Torrezan, PhD
Clinical and Functional Genomics Group
Hospital A. C. Camargo
São Paulo, Brazil
The knowledge gained from this study will be invaluable to effectively guide diagnostic and prevention strategies in patients at risk for hereditary CRC and other MAP-related tumors and will set the framework to apply somatic analysis for MUTYH variant classification. Moreover, this project is in perfect alignment to the CGA-IGC mission, as it will advance science and clinical care of inherited gastrointestinal cancers through research and help to promote awareness of this condition in Brazil and other Latin America countries. Patients and family members with a genetic predisposition for polyposis and CRC will benefit from appropriate regular surveillance, preventive measures (such as adenomas removal) and consequently decrease in the incidence of colorectal cancer.
"The Collaborative Group of the Americas on Inherited Gastrointestinal Cancers has been funding projects to advance the care of patients and families with hereditary cancers syndromes since 2012. CGA-IGC’s continued investment in career development will foster clinical innovations and mold our future leaders."
CGA-IGC President, Swati G. Patel
While Dr Torrezan is unable to attend the CGA-IGC Annual meeting this year. Her award will be announced by Dr Elena Stoffel from the CGA-IGC Grants Committee at the CGA-IGC Awards ceremony taking place on Thursday November 10th from 4:30-6:00pm.